# US Continuous Glucose Monitoring System Market > US Continuous Glucose Monitoring System Market Research Report: Size, Share, Trend Analysis By Applications (Diabetes Management, Critical Care, Sports Nutrition), By Product Type (Sensor, Transmitter, Receiver, Integrated Device), By End-user (Hospitals, Homecare, Diabetes Clinics), and By Technology (Microdialysis, Spectroscopy, Electrochemical) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 12.34% - **2024:** $ 2,450 Million - **2025:** $ 2,752.33 Million - **2035:** $ 8,813.14 Million - **Key Players:** Dexcom (US), Abbott (US), Medtronic (US), Roche (CH), Senseonics (US), GlucoMe (IL), Insulet (US), B. Braun (DE) **Report ID:** MRFR/MED/48488-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-continuous-glucose-monitoring-system-market-50245 --- ## Market Summary ## **US Continuous Glucose Monitoring System Market Overview** As per MRFR analysis, the US Continuous Glucose Monitoring System Market Size was estimated at 1.04 (USD Billion) in 2023. The US Continuous Glucose Monitoring System Market is expected to grow from 1.15 (USD Billion) in 2024 to 3 (USD Billion) by 2035. The US Continuous Glucose Monitoring System Market CAGR (growth rate) is expected to be around 9.108% during the forecast period (2025 - 2035). ### **Key US Continuous Glucose Monitoring System Market Trends Highlighted** A number of important factors are driving the market for continuous glucose monitoring systems in the US. The rising incidence of diabetes, especially Type 1 and Type 2, is a major factor that has increased demand for sophisticated monitoring systems. Millions of Americans have diabetes, according to the American Diabetes Association, which increases the demand for more accurate and effective glucose management devices like CGMs. There is a chance to investigate ways to make things easier to use and integrate with smartphone apps for real-time monitoring as technology develops. For both patients and healthcare professionals, this can simplify the management of diabetes. CGMs are customized to meet the needs of each patient, following a discernible trend in healthcare towards personalization in recent years. The requirement for more dependable and user-friendly equipment is met by innovations including longer wear times and improved sensor accuracy. Additionally, regulatory assistance from agencies such as the FDA has expedited product approvals, creating an atmosphere that is favorable for market expansion. Patients may now better manage their conditions from the comfort of their homes thanks to new options brought about by the trend towards telehealth and remote patient monitoring. Additionally, diabetes self-management education and awareness initiatives are gaining momentum, which might increase market penetration as more people learn about the advantages of CGMs. Exciting opportunities for the future of diabetes care in the US are also presented by the integration of CGMs with health data platforms and ongoing advancements in device connection, which will eventually improve patient outcomes and the effectiveness of healthcare as a whole. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Continuous Glucose Monitoring System Market Drivers** ### **Increasing Prevalence of Diabetes in the United States** The rising prevalence of diabetes in the United States is one of the most significant drivers of growth in the US Continuous Glucose Monitoring System Market. According to the Centers for Disease Control and Prevention (CDC), as of 2020, approximately 34.2 million Americans had diabetes, accounting for about 10.5 percent of the population. This figure represents a substantial increase from previous years, indicating a growing need for effective management solutions such as continuous glucose monitors. Established organizations like the American Diabetes Association (ADA) advocate for the adoption of advanced glucose monitoring technologies, which aligns with the increasing patient needs for precise and convenient blood sugar management. As diabetes cases are projected to rise further, the demand for continuous glucose monitoring systems will continue to gain momentum, driving market growth significantly in the upcoming years. ### **Technological Advancements in Continuous Glucose Monitoring Systems** Technological advancements significantly impact the US Continuous Glucose Monitoring System Market by enhancing device accuracy and user experience. Innovations such as smaller sensor sizes, longer wear times, and smartphone integrations have made continuous glucose monitors more appealing to consumers. According to the Food and Drug Administration (FDA), new technologies have been successfully approved that allow real-time data sharing and cloud-based analytics, providing patients with valuable insights into their glucose levels. Companies like Abbott Laboratories and Dexcom are at the forefront of these advancements, demonstrating how modern solutions can significantly improve the quality of life for diabetic patients. As these technologies become more widespread, it will likely lead to increased adoption and sustained market growth. ### **Rising Awareness and Education Regarding Diabetes Management** There is a growing awareness among the US population regarding diabetes management, which significantly contributes to the growth of the US Continuous Glucose Monitoring System Market. Initiatives by organizations like the American Association of Clinical Endocrinology (AACE) aim to educate patients about diabetes management tools, including continuous glucose monitoring systems. According to estimates from AACE, nearly 50% of people with diabetes do not use effective monitoring tools. However, as informed patients begin to understand the benefits and accuracy of continuous glucose monitoring, adoption rates are increasing. This heightened awareness drives demand for innovative monitoring solutions, creating opportunities for market players and contributing to overall industry growth. ### **Growing Geriatric Population in the United States** The increasing geriatric population in the United States presents another significant driver for the US Continuous Glucose Monitoring System Market. As per the US Census Bureau, the number of individuals aged 65 and older is projected to reach over 80 million by 2040, doubling currently estimated figures. Older adults are at a greater risk of developing diabetes and require more effective monitoring options. Organizations such as the American Geriatrics Society are advocating for better diabetes care management tools among the elderly, promoting the need for continuous glucose monitoring systems. This demographic shift signals a growing market potential, necessitating the development of tailored solutions to cater to the needs of this expanding segment. ## **US Continuous Glucose Monitoring System Market Segment Insights** ### **Continuous Glucose Monitoring System Market Application Insights** The Application segment of the US Continuous Glucose Monitoring System Market plays a pivotal role in addressing various health management needs. This segment is primarily significant for Diabetes Management, where Continuous Glucose Monitoring (CGM) systems are crucial for real-time tracking of glucose levels, thus allowing individuals to make informed decisions regarding insulin administration and dietary habits. As the prevalence of diabetes continues to rise in the US, driven by factors like an increase in obesity and sedentary lifestyles, this segment has seen significant expansion, with technologies making it more accessible and user-friendly. In Critical Care settings, CGM systems enable healthcare providers to monitor patients’ glucose levels continuously, which is essential for managing patients in emergency or intensive care situations. The capability to track glucose levels accurately aids in preventing complications and facilitates timely interventions. Moreover, the Sports Nutrition aspect of the Application segment is gaining traction, as athletes and fitness enthusiasts use CGM systems to optimize their performance through better glucose management. This growing awareness around nutrition and health among athletes, alongside the increasing focus on personalized fitness regimens, is propelling innovations in CGM technologies tailored for sports applications. Overall, this segment addresses a wide range of health applications, underlining its importance in the US market, with advancements in technology driving growth and improving lives across different demographics. The US market sees a unique blend of therapeutic utilization in diabetes care and preventive measures in sports nutrition, showcasing how Continuous Glucose Monitoring systems can have diverse applications, thus emphasizing their versatility and relevance in today’s health landscape. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Continuous Glucose Monitoring System Market Product Type Insights** The US [Continuous Glucose Monitoring System Market](../../../reports/continuous-glucose-monitoring-system-market-20310) is prominently segmented into several Product Types, which include Sensors, Transmitters, Receivers, and Integrated Devices. Each of these segments plays a crucial role in the overall functioning and effectiveness of glucose monitoring systems. Sensors are essential as they provide real-time glucose readings, allowing for timely interventions. Transmitters facilitate the wireless communication of glucose data from the sensor to the receiver, enhancing user convenience and real-time monitoring. Receivers are critical, serving as the display devices for the glucose readings and helping users track their data efficiently. Integrated devices combine these functions, offering a streamlined solution that appeals to users looking for a comprehensive monitoring experience. The growth in the prevalence of diabetes in the US, driven by factors such as dietary habits and sedentary lifestyles, is propelling the demand for these products. Moreover, advancements in technology are continuously improving the accuracy and usability of these devices, drawing attention from both healthcare providers and patients. As awareness about diabetes management grows, these segments are expected to gain significant traction, enhancing accessibility and encouragement towards effective glucose monitoring solutions. Challenges such as affordability and technological limitations remain, but the market presents numerous opportunities for innovation and improved patient care. ### **Continuous Glucose Monitoring System Market End-user Insights** The US Continuous Glucose Monitoring System Market is experiencing substantial growth across various End-users, reflecting the increasing prevalence of diabetes and the demand for better glucose management solutions. Hospitals play a crucial role in this ecosystem by utilizing advanced CGM systems to enhance patient care in acute settings, improving clinical outcomes and patient safety during hospitalization. Homecare segments are also gaining prominence, with patients preferring convenient solutions for monitoring their glucose levels from the comfort of their homes, thus promoting better adherence to management plans. Diabetes clinics provide specialized support and education, leading to tailored treatment plans that integrate CGM technology, which aids in more effective diabetes management. Together, these End-users are vital in expanding the reach of Continuous Glucose Monitoring System services, each contributing uniquely to the overall market dynamics, while addressing the needs of diverse patient populations and driving improvements in diabetes care across the United States. As more innovations emerge, the role of these segments will continue to evolve, creating opportunities for better health outcomes and higher quality of life for individuals with diabetes. ### **Continuous Glucose Monitoring System Market Technology Insights** The US Continuous Glucose Monitoring System Market is evolving significantly within the Technology segment, showcasing a variety of advanced methodologies that cater to the growing demand for effective glucose management solutions. Microdialysis emerges as an important technique known for its ability to provide continuous monitoring and real-time data, making it valuable for diabetes management. Spectroscopy is also gaining traction, offering non-invasive glucose monitoring options that can enhance patient compliance and ease of use, thus representing a growing preference among users. The electrochemical approach dominates the landscape due to its cost-effectiveness and reliability, appealing to both healthcare providers and patients alike. The combination of these technologies responds to increasing demand in the US, driven by factors such as the rising prevalence of diabetes and the need for continuous health monitoring solutions. Additionally, there are regulatory efforts focused on enhancing the approval processes for innovative devices, which may further propel the advancements in these technologies within the US market. ## **US Continuous Glucose Monitoring System Market Key Players and Competitive Insights** The US Continuous Glucose Monitoring System Market is undergoing significant transformation, driven by advancements in technology, increasing prevalence of diabetes, and a growing emphasis on personalized healthcare. Competitive insights in this sector reveal a dynamic landscape where innovation and strategic partnerships play pivotal roles in shaping market trends. Companies are aggressively developing solutions that not only provide real-time glucose monitoring but also integrate data analytics and mobile applications for a comprehensive management platform. The market is characterized by a mix of established players and emerging startups, all striving to capture market share within a landscape that increasingly prioritizes user experience and healthcare outcomes. As consumers become more informed and proactive in managing their health, the competition intensifies, prompting companies to enhance their product offerings and invest in research and development. In the US market, Freestyle stands out for its robust lineup of continuous glucose monitoring products that cater to a diverse demographic of users, ranging from children to adults. The company has established a strong brand presence by emphasizing ease of use and accuracy of its devices. Freestyle's strengths lie in its innovative technology that allows for minimally invasive glucose monitoring, providing users with real-time data that is both accessible and actionable. Moreover, the user-friendly interface of Freestyle devices encourages greater engagement and adherence among users, enhancing overall diabetes management. The commitment to continuous improvement and customer feedback has enabled Freestyle to build a loyal customer base while also capturing the attention of healthcare professionals who recommend its products for reliable glucose monitoring solutions. Medtronic, a prominent player in the US Continuous Glucose Monitoring System Market, offers an extensive range of products and services that meet the diverse needs of insulin-dependent diabetes patients. Known for its flagship continuous glucose monitoring systems, Medtronic combines advanced sensor technology with integrated insulin delivery solutions to provide a comprehensive diabetes management platform. The company’s strengths include a significant investment in research and development, enabling it to introduce cutting-edge technologies that improve the accuracy and reliability of glucose readings. Medtronic’s strategic mergers and acquisitions have further solidified its market presence, allowing it to enhance its product offerings and expand its customer reach. By focusing on patient-centric innovations and establishing partnerships with healthcare providers, Medtronic aims to enhance the quality of life for diabetes patients while solidifying its status as a leader in the continuous glucose monitoring space in the United States. ### **Key Companies in the US Continuous Glucose Monitoring System Market Include** - **[Freestyle](https://www.freestyle.abbott/in-en/home.html)** - Medtronic - Abbott Laboratories - Dexcom - Senseonics - Ascensia Diabetes Care - Ypsomed - Roche - Tandem Diabetes Care - Insulet Corporation - Johnson and Johnson - Becton Dickinson ## **US Continuous Glucose Monitoring System Market Developments** In recent months, the US Continuous Glucose Monitoring System Market has experienced significant advancements and developments. Notably, Abbott Laboratories has reported growth in their FreeStyle Libre technology, with a wider acceptance among diabetic patients leading to a substantial increase in market share in the sector as of September 2023. Medtronic has also introduced its latest continuous glucose monitoring systems, which integrate with insulin pumps, reflecting the trend toward more integrated diabetes management solutions. In August 2023, Dexcom announced a partnership to enhance its data-sharing capabilities, further increasing the efficacy of diabetes management for users. Additionally, in May 2023, a merger between Ascensia Diabetes Care and Ypsomed was made public, allowing for the development of more innovative solutions in the CGM space. The US market is witnessing a rising demand for wearable glucose monitoring devices due to the increasing prevalence of diabetes; as of 2022, an estimated 37 million Americans are living with diabetes. The valuation of the continuous glucose monitoring market has also reached around $4 billion, indicating robust growth potential and significant investments in new technologies and research by companies such as Johnson and Johnson, Becton Dickinson, and Tandem Diabetes Care. ## **US Continuous Glucose Monitoring System Market Segmentation Insights** ### **Continuous Glucose Monitoring System Market Application Outlook** - Diabetes Management - Critical Care - Sports Nutrition ### **Continuous Glucose Monitoring System Market Product Type Outlook** - Sensor - Transmitter - Receiver - Integrated Device ### **Continuous Glucose Monitoring System Market End-user Outlook** - Hospitals - Homecare - Diabetes Clinics ### **Continuous Glucose Monitoring System Market Technology Outlook** - Microdialysis - Spectroscopy - Electrochemical ## Market Drivers ### Rising Healthcare Expenditure The continuous glucose-monitoring-system market is also driven by rising healthcare expenditure in the United States. As healthcare spending continues to increase, there is a greater allocation of resources towards innovative medical technologies, including continuous glucose monitoring systems. According to the National Health Expenditure Accounts, healthcare spending in the U.S. is projected to reach $6.2 trillion by 2028. This financial commitment to advanced healthcare solutions suggests a favorable environment for the continuous glucose-monitoring-system market, as both public and private sectors invest in technologies that enhance patient care and improve health outcomes. ### Rising Prevalence of Diabetes The continuous glucose-monitoring-system market is experiencing growth due to the rising prevalence of diabetes in the United States. According to the Centers for Disease Control and Prevention (CDC), approximately 34.2 million Americans, or 10.5% of the population, have diabetes. This increasing number of individuals requiring effective glucose management solutions drives demand for continuous glucose monitoring systems. As diabetes management becomes more critical, healthcare providers and patients are seeking advanced technologies that offer real-time data and insights. The continuous glucose-monitoring-system market is thus positioned to expand, as these systems provide essential support for individuals managing diabetes, potentially improving health outcomes and reducing long-term complications. ### Increased Focus on Preventive Healthcare The continuous glucose-monitoring-system market is influenced by the increased focus on preventive healthcare in the United States. As healthcare systems emphasize early intervention and disease prevention, continuous glucose monitoring emerges as a vital tool for identifying glucose irregularities before they escalate into more serious health issues. This proactive approach not only aids in diabetes management but also contributes to overall public health. The market is expected to grow as healthcare policies increasingly support preventive measures, encouraging the adoption of continuous glucose-monitoring systems among at-risk populations. ### Growing Demand for Home Healthcare Solutions The continuous glucose-monitoring-system market is benefiting from the growing demand for home healthcare solutions. As more patients prefer to manage their health conditions at home, the need for reliable and efficient monitoring systems has surged. The convenience of continuous glucose monitoring allows individuals to track their glucose levels without frequent visits to healthcare facilities. This trend is particularly relevant in the context of chronic disease management, where patients seek to maintain their health autonomously. The market is likely to expand as healthcare providers increasingly recommend these systems for home use, aligning with the broader shift towards patient-centered care. ### Technological Innovations in Monitoring Devices Technological innovations are significantly impacting the continuous glucose-monitoring-system market. Recent advancements in sensor technology, data analytics, and mobile connectivity have led to the development of more accurate and user-friendly monitoring devices. For instance, the introduction of devices that integrate with smartphones allows users to track their glucose levels seamlessly. The market is projected to grow as these innovations enhance user experience and compliance. Furthermore, the integration of artificial intelligence in data interpretation may provide personalized insights, making it easier for users to manage their diabetes effectively. This trend indicates a shift towards more sophisticated solutions in the continuous glucose-monitoring-system market. ## Future Outlook The [Continuous Glucose Monitoring System Market](https://www.marketresearchfuture.com/reports/continuous-glucose-monitoring-system-market-20310) is projected to grow at a 12.34% CAGR from 2025 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising consumer awareness. **New opportunities:** - Development of integrated health management platforms for real-time data sharing. Expansion of subscription-based models for continuous glucose monitoring devices. Partnerships with telehealth providers to enhance remote patient monitoring services. By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in diabetes management solutions. ## Segment Insights ### By Application: Diabetes Management (Largest) vs. Sports Nutrition (Fastest-Growing) The market share distribution in the US continuous glucose-monitoring-system market reveals that Diabetes Management holds the largest segment, driven by the increasing prevalence of diabetes and the growing adoption of CGM technology among patients. Critical Care follows as a significant contributor, especially in hospital settings, while Sports Nutrition is emerging rapidly due to the rising interest in health and fitness among consumers. Growth trends indicate a robust expansion in the Diabetes Management segment, fueled by technological advancements and the need for continuous monitoring of glucose levels. Conversely, Sports Nutrition is witnessing accelerated growth, propelled by an active lifestyle trend and the integration of CGMs into sports and fitness regimens, emphasizing enhanced performance and health monitoring. Diabetes Management (Dominant) vs. Critical Care (Emerging) Diabetes Management remains the dominant application in the US continuous glucose-monitoring-system market, characterized by a substantial user base and widespread acceptance among diabetic patients. This segment benefits from continual innovations, ensuring accurate readings and user-friendly designs that cater to individual needs. In contrast, the Critical Care segment, while emerging, is gaining traction as healthcare providers increasingly recognize the importance of real-time glucose monitoring for critically ill patients. Both segments reflect the broader trends of personalized healthcare and the move towards proactive management of health conditions, highlighting the potential for robust growth and investment in this area. ### By Product Type: Sensor (Largest) vs. Integrated Device (Fastest-Growing) In the US continuous glucose-monitoring-system market, the market share distribution reflects a significant prevalence of Sensor devices, which dominate the segment due to their widespread acceptance and reliability in monitoring glucose levels. Transmitters and Receivers follow, showing steady contributions but not quite matching the popularity of Sensors. Integrated Devices are gaining traction as they offer comprehensive solutions that combine functionalities, appealing especially to tech-savvy consumers seeking convenience. Sensor (Dominant) vs. Integrated Device (Emerging) Sensors are a cornerstone of glucose monitoring in the market, offering high precision and consistent performance that cater to the needs of patients and healthcare providers alike. They hold the dominant position due to their established technologies and reliability. On the other hand, Integrated Devices represent an emerging trend, rapidly capturing market interest by combining glucose monitoring with smartphone connectivity and health tracking functionalities. This integration appeals particularly to younger demographics desiring more manageable and user-friendly health monitoring options. As technology advances, the competition between these two segments is expected to intensify, driving innovation and enhancing patient experiences. ### By End User: Hospitals (Largest) vs. Homecare (Fastest-Growing) In the US continuous glucose-monitoring-system market, hospitals represent the largest segment, driven by their capacity to provide comprehensive care for diabetes management. With advanced technology and a wide range of resources, hospitals cater to a significant portion of glucose monitoring needs, ensuring patients receive timely and accurate information regarding their glucose levels. On the other hand, homecare has emerged as a rapidly growing segment, appealing to patients' increasing preference for monitoring their health in the comfort of their homes. This shift not only indicates a change in patient behavior but also emphasizes the importance of convenience in diabetes management today. The growth trends within the end-user segment reflect evolving healthcare dynamics, with homecare systems gaining traction due to technological advancements and an aging population. The COVID-19 pandemic has accelerated this shift, prompting patients to seek remote monitoring solutions. Additionally, the proliferation of digital health technologies, enabling easier and more reliable home monitoring, significantly contributes to the rise of the homecare segment, which is expected to see sustained growth. Conversely, while hospitals will continue to play a crucial role, their growth rate may stabilize as homecare becomes more prevalent in diabetes management. Hospitals (Dominant) vs. Homecare (Emerging) Hospitals are a dominant force in the US continuous glucose-monitoring-system market, providing critical care and resources essential for managing diabetes. They incorporate state-of-the-art technology and skilled healthcare professionals to facilitate effective monitoring and treatment options. This segment thrives on the sophisticated infrastructure that hospitals have in place, allowing for timely interventions and comprehensive patient care. Meanwhile, homecare stands out as an emerging segment due to changes in patient preferences and advancements in technology that allow individuals to track their glucose levels conveniently at home. Homecare solutions often focus on user-friendly devices integrated with mobile applications, enabling real-time data sharing with healthcare providers. The evolving landscape of the US continuous glucose-monitoring-system market suggests that while hospitals will maintain their significance, homecare is rapidly becoming a vital aspect of diabetes management. ### By Technology: Electrochemical (Largest) vs. Microdialysis (Fastest-Growing) The market share distribution within the technology segment of the continuous glucose-monitoring system indicates that electrochemical monitoring systems currently hold the largest share. This is largely attributed to their reliability and affordability, which have resulted in their widespread adoption among consumers. Meanwhile, microdialysis technology, though holding a smaller share, is gaining traction rapidly due to its advanced capabilities in real-time monitoring, which appeals to both healthcare providers and patients. Growth trends in the US continuous glucose-monitoring system market suggest that the microdialysis method is emerging as a significant player. Drivers of this growth include increasing demand for precise glucose monitoring and ongoing technological advancements. Meanwhile, electrochemical systems are expected to maintain dominance as they continue to develop more efficient models. The dual growth of both segments illustrates a dynamic market adjusting to consumer needs. Technology: Electrochemical (Dominant) vs. Microdialysis (Emerging) Electrochemical technology has become the dominant force in the continuous glucose-monitoring system market, celebrated for its affordability and ease of use, making it a preferred choice for many patients. Its ability to deliver accurate glucose readings has solidified its position, although it constantly faces pressure to evolve. In contrast, microdialysis technology is emerging rapidly, gaining popularity due to its innovative approach in providing real-time glucose levels, enhancing patient care and management. This segment is gaining interest for its potential applications in difficult patient demographics, such as those experiencing insulin resistance or requiring more detailed metabolic monitoring. Both technologies play crucial roles in the overall landscape of glucose monitoring. ## Competitive Benchmarking The continuous glucose-monitoring-system market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for diabetes management solutions. Key players such as Dexcom (US), Abbott (US), and Medtronic (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Dexcom (US) focuses on innovation, particularly in developing next-generation sensors that offer improved accuracy and user experience. Abbott (US) emphasizes regional expansion, particularly in underserved markets, while Medtronic (US) is leveraging partnerships to integrate its systems with digital health platforms, thereby enhancing patient engagement and data utilization. Collectively, these strategies contribute to a competitive environment that is increasingly centered around technological innovation and patient-centric solutions.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set industry standards and drive innovation. This competitive structure fosters an environment where smaller firms can thrive by focusing on niche markets or specialized technologies. In October Abbott (US) announced the launch of its latest continuous glucose monitor, which features a new algorithm designed to provide real-time glucose readings with enhanced accuracy. This strategic move is significant as it not only reinforces Abbott's commitment to innovation but also positions the company to capture a larger share of the growing demand for reliable diabetes management tools. The introduction of this technology is likely to attract both new users and healthcare providers, further solidifying Abbott's market presence. In September Dexcom (US) entered into a strategic partnership with a leading telehealth provider to integrate its glucose monitoring systems with remote patient monitoring services. This collaboration is indicative of a broader trend towards digital health solutions, allowing for more comprehensive diabetes management. By aligning with telehealth services, Dexcom (US) enhances its value proposition, making it easier for patients to access their data and receive timely interventions, which could lead to improved health outcomes. In August Medtronic (US) expanded its product offerings by acquiring a startup specializing in artificial intelligence-driven analytics for diabetes management. This acquisition is pivotal as it not only broadens Medtronic's technological capabilities but also aligns with the growing trend of integrating AI into healthcare solutions. The incorporation of AI analytics is expected to provide users with personalized insights, thereby enhancing the overall effectiveness of diabetes management systems. As of November current competitive trends in the continuous glucose-monitoring-system market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to leverage complementary strengths and enhance their product offerings. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, advanced technology, and supply chain reliability. This shift underscores the importance of developing robust, user-friendly solutions that meet the evolving needs of patients and healthcare providers alike. ## Recent News & Developments In recent months, the US Continuous Glucose Monitoring System Market has experienced significant advancements and developments. Notably, Abbott Laboratories has reported growth in their FreeStyle Libre technology, with a wider acceptance among diabetic patients leading to a substantial increase in market share in the sector as of September 2023. Medtronic has also introduced its latest continuous glucose monitoring systems, which integrate with insulin pumps, reflecting the trend toward more integrated diabetes management solutions. In August 2023, Dexcom announced a partnership to enhance its data-sharing capabilities, further increasing the efficacy of diabetes management for users. Additionally, in May 2023, a merger between Ascensia Diabetes Care and Ypsomed was made public, allowing for the development of more innovative solutions in the CGM space. The US market is witnessing a rising demand for wearable glucose monitoring devices due to the increasing prevalence of diabetes; as of 2022, an estimated 37 million Americans are living with diabetes. The valuation of the continuous glucose monitoring market has also reached around $4 billion, indicating robust growth potential and significant investments in new technologies and research by companies such as Johnson and Johnson, Becton Dickinson, and Tandem Diabetes Care. ## Report Scope | MARKET SIZE 2024 | 2450.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 2752.33(USD Million) | | MARKET SIZE 2035 | 8813.14(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.34% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Dexcom (US), Abbott (US), Medtronic (US), Roche (CH), Senseonics (US), GlucoMe (IL), Insulet (US), B. Braun (DE) | | Segments Covered | Application, Product Type, End User, Technology | | Key Market Opportunities | Integration of artificial intelligence in continuous glucose-monitoring-system for personalized diabetes management solutions. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the continuous glucose-monitoring-system market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US continuous glucose-monitoring-system market?** A: The market valuation was $2450.0 Million in 2024. **Q: What is the projected market size for the US continuous glucose-monitoring-system market by 2035?** A: The market is projected to reach $8813.14 Million by 2035. **Q: What is the expected CAGR for the US continuous glucose-monitoring-system market during the forecast period 2025 - 2035?** A: The expected CAGR is 12.34% during the forecast period 2025 - 2035. **Q: Which application segment had the highest valuation in 2024?** A: The Diabetes Management segment had the highest valuation at $1225.0 Million in 2024. **Q: What are the key product types in the US continuous glucose-monitoring-system market?** A: Key product types include Sensors, Transmitters, Receivers, and Integrated Devices. **Q: Which end user segment is projected to grow the most by 2035?** A: The Homecare segment is projected to grow significantly, reaching $5000.0 Million by 2035. **Q: Who are the leading companies in the US continuous glucose-monitoring-system market?** A: Key players include Dexcom, Abbott, Medtronic, Roche, Senseonics, GlucoMe, Insulet, and B. Braun. **Q: What technology segment is expected to show the highest growth by 2035?** A: The Electrochemical technology segment is expected to show substantial growth, reaching $4813.14 Million by 2035. **Q: How did the Critical Care application segment perform in 2024?** A: The Critical Care application segment was valued at $735.0 Million in 2024. **Q: What is the projected valuation for the Integrated Device product type by 2035?** A: The Integrated Device product type is projected to reach $4113.14 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-continuous-glucose-monitoring-system-market-50245*